• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pandemic A/H1N1v Influenza 2009 in hospitalized children: a multicenter Belgian survey

tetano

Editor, Senior Moderator
During the 2009 influenza A/H1N1v pandemic, children were identified as a specific "at risk"group. We conducted a multicentric study to describe pattern of influenza A/H1N1v infection among hospitalized children in Brussels, Belgium.

Methods: From July 1, 2009, to January 31, 2010, we collected epidemiological and clinical data of all proven (positive H1N1v PCR) and probable (positive influenza A antigen or culture) pediatric cases of influenza A/H1N1v infections, hospitalized in four tertiary centers.

Results: During the epidemic period, an excess of 18% of pediatric outpatients and emergency department visits was registered.

215 children were hospitalized with proven/probable influenza A/H1N1v infection. Median age was 31 months.

47% had [greater than or equal to] 1 comorbid conditions. Febrile respiratory illness was the most common presentation.

36% presented with initial gastrointestinal symptoms and 10% with neurological manifestations. 34% had pneumonia.

Only 24% of the patients received oseltamivir but 57% received antibiotics. 10% of children were admitted to PICU, seven of whom with ARDS.

Case fatality-rate was 5/215 (2%), concerning only children suffering from chronic neurological disorders. Children over 2 years of age showed a higher propensity to be admitted to PICU (16% vs 1%, p=0.002) and a higher mortality rate (4% vs 0%, p=0.06).

Infants less than 3 months old showed a milder course of infection, with few respiratory and neurological complications.

Conclusion: Although influenza A/H1N1v infections were generally self-limited, pediatric burden of disease was significant. Compared to other countries experiencing different health care systems, our Belgian cohort was younger and received less frequently antiviral therapy; disease course and mortality were however similar.

Author: Sophie BlumentalElisabeth HuismanMarie-Coralie CornetChristine FerreiroIris De SchutterMarijke ReyndersIngrid WyboBenoit Kabamba-MukadiRuth ArmanoDominique HermansMarie-Cecile NassogneBhavna MahadebChristine FonteyneGerlant Van BerlaerJack LevyDid


http://7thspace.com/headlines/39915...ampaign=Feed: 7thspace (7thSpace Interactive)
 
Back
Top Bottom